ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

0QNV Addex Therapeutics Ltd

3,02
0,00 (0,00%)
31 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Addex Therapeutics Ltd 0QNV London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 3,02 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,02 3,02
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
31/5/202407:00UKREGAddex Therapeutics to Release Q1 2024 Financial Results and..
08/5/202407:00UKREGAddex to Present at Bio€quity Europe 2024
29/4/202407:00UKREGAddex Provides Update on ADX71149 Phase 2 Epilepsy Study
19/4/202407:00UKREGAddex to Present at the Swiss Biotech Day 2024
18/4/202407:00UKREGAddex Therapeutics Reports Full Year 2023 Financial Results..
11/4/202407:00UKREGAddex Therapeutics to Release Full-Year 2023 Financial..
03/4/202407:00UKREGAddex and Perceptive Launch Neurosterix with $63 Million to..
14/3/202407:00UKREGAddex to Present at the Bio-Europe Spring 2024 Conference
31/1/202407:00UKREGAddex Enters into At-The-Market ADS Offering Agreement with..
09/1/202407:00GLOBEAddex to Present at the Swiss Equities Baader Conference
05/1/202407:30GLOBEAddex to Present at Biotech Showcase™ 2024
20/12/202307:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
14/12/202307:00GLOBEAddex Creates Treasury Shares
29/11/202307:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
28/11/202307:00GLOBEAddex Convenes Extraordinary General Meeting
23/11/202307:00GLOBEAddex Therapeutics to Release Third Quarter 2023 Financial..
14/11/202307:00GLOBEAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
08/11/202307:00GLOBEAddex Regains Nasdaq Listing Compliance
02/11/202307:00GLOBEAddex Announces Participation in the Bio-Europe 2023..
20/10/202307:00GLOBEAddex Completes ADS Ratio Change
06/10/202322:00GLOBEAddex Announces Plan to Implement ADS Ratio Change
20/9/202307:00GLOBEAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
06/9/202307:00GLOBEAddex Announces Participation in the H.C. Wainwright 25th..
05/9/202307:00GLOBEAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
04/9/202307:00GLOBEAddex’s Dipraglurant Development in Post-Stroke Recovery..
10/8/202307:00GLOBEAddex Reports 2023 Half Year and Second Quarter Financial..
04/8/202307:00GLOBEAddex Therapeutics to Release Half-Year 2023 Financial..
03/8/202307:00GLOBEAddex GABAB Positive Allosteric Modulator Program to Receive..
24/7/202307:00GLOBEAddex mGlu2PAM Demonstrates Potential in Substance Use..
15/6/202307:00GLOBEAddex Increases Issued Share Capital to Create Treasury..